Back to Clinical Trials Overview

Your search for "HIV AIDS" returned 16 results:


A Phase 3b, Randomized, Double-Blind Switch Study to Evaluate the Safety and Efficacy of Emtricitabine/ Rilpivirine/ Tenofovir Alafenamide (FTC/RPV/TAF) Fixed Dose Combination (FDC) in HIV-1 Positive Subjects who are Virologically-Suppressed on Emtricitabine/ Rilpivirine/ Tenofovir Disoproxil Fumarate (FTC/RPV/TDF)
Principal Investigator(s): Judith Aberg

A Multi-arm, Phase 3, Randomized, Placebo Controlled, Double Blind Clinical Trial to Investigate the Efficacy and Safety of BMS-663068/ GSK3684934 in Heavily Treatment Experienced Subjects Infected with Multi-drug Resistant HIV-1
Principal Investigator(s): Judith Aberg

Treatment Adherence through the Advanced Use of Technology
Principal Investigator(s): Judith Aberg

A Phase III, Randomized, Multicenter, Parallel-group, Open-Label Study Evaluating the Efficacy, Safety, and Tolerability of Long-Acting Intramuscular Cabotegravir and Rilpivirine for Maintenance of Virologic Suppression Following Switch from an Integrase Inhibitor Single Tablet Regimen in HIV-1 Infected Antiretroviral Therapy Naive Adult Participants
Principal Investigator(s): Judith Aberg

Effects of Mindfulness Training on Chronic Inflammation in HIV-Infected Adults
Principal Investigator(s): Jeffrey Weiss

A Phase 3, Randomized, Double-blind Study to Evaluate the Safety and Efficacy of Emtricitabine and Tenofovir Alafenamide (F/TAF) Fixed-Dose Combination Once Daily for Pre-Exposure Prophylaxis in Men and Transgender Women Who Have Sex with Men and Are at Risk of HIV-1 Infection
Principal Investigator(s): Michelle Cespedes

A Structural Intervention to Improve Substance Abuse Diagnosis and Treatment Practices in HIV Clinic Settings
Principal Investigator(s): Judith Aberg

A Phase 3b, Randomized, Double-Blind Switch Study to Evaluate the Safety and Efficacy of Emtricitabine/ Rilpivirine/ Tenofovir Alafenamide (FTC/RPV/TAF) Fixed Dose Combination (FDC) in HIV-1 Positive Subjects who are Virologically-Suppressed on Emtricitabine/ Rilpivirine/ Tenofovir Disoproxil Fumarate (FTC/RPV/TDF)
Principal Investigator(s): Judith Aberg

The Manhattan HIV Brain Bank
Principal Investigator(s): Morgello, Susan

Effects of Early-Life Stress on Brain Dysfunction in HIV+ Adults (Project STRIVE)
Principal Investigator(s): Uraina Clark

Randomized Trial to Prevent Vascular Events in HIV - REPRIEVE
Principal Investigator(s): Judith Aberg

Targeting Platelets in Chronic HIV Infection
Principal Investigator(s): Meagan O'Brien

A Phase III, randomized, multicenter, parallel-group, non-inferiority, open-label study evaluating the efficacy, safety, and tolerability of switching to long-acting cabotegravir plus long-acting rilpivirine from current INI- NNRTI-, or PI-based antiretroviral regimen in HIV-1-infected adults who are virologically suppressed
Principal Investigator(s): Judith Aberg

Studies of Ocular Complications of AIDS
Principal Investigator(s): Jabs, Douglas A

Metabolic effects of antiretrovirals in exposed HIV seronegative children
Principal Investigator(s): Jao, Jennifer, MD

Intervention to Improve HCV Treatment Uptake and Adherence in HIV/HCV Coinfection
Principal Investigator(s): Jeffrey Weiss